CD4 Count Slope and Mortality in HIV-Infected Patients on Antiretroviral Therapy | Zendy

Christopher J. Hoffmann | Zendy; Michael Schomaker | Zendy; Matthew P. Fox | Zendy; Portia Mutevedzi | Zendy; Janet Giddy | Zendy; Hans Prozesky | Zendy; Robin Wood | Zendy; Daniela Garone | Zendy; Matthias Egger | Zendy; Andrew Boulle | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

CD4 Count Slope and Mortality in HIV-Infected Patients on Antiretroviral Therapy

Author(s) -

Christopher J. Hoffmann,

Michael Schomaker,

Matthew P. Fox,

Portia Mutevedzi,

Janet Giddy,

Hans Prozesky,

Robin Wood,

Daniela Garone,

Matthias Egger,

Andrew Boulle

Publication year - 2013

Publication title -

jaids journal of acquired immune deficiency syndromes

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.162

H-Index - 157

eISSN - 1944-7884

pISSN - 1525-4135

DOI - 10.1097/qai.0b013e318287c1fe

Subject(s) - cart , hazard ratio , confidence interval , medicine , liter , viral load , antiretroviral therapy , human immunodeficiency virus (hiv) , proportional hazards model , immunology , gastroenterology , mechanical engineering , engineering

In many resource-limited settings monitoring of combination antiretroviral therapy (cART) is based on the current CD4 count, with limited access to HIV RNA tests or laboratory diagnostics. We examined whether the CD4 count slope over 6 months could provide additional prognostic information.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research